mHealth App for Acid Reflux
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new mobile health (mHealth) app designed to help individuals with gastroesophageal reflux disease (GERD) manage their symptoms more effectively. The mHealth Question Prompt List app aims to enhance patient-doctor communication by encouraging patients to ask pertinent questions. Participants will provide feedback on living with GERD and the app itself, then use the app to determine if it helps them feel more in control compared to usual care. This trial suits English-speaking participants with a clinical diagnosis of GERD who use medication and have internet access. As an unphased trial, it offers participants the chance to contribute to innovative research that could improve GERD management for many.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop your current medications. However, it requires documented use of PPIs (medications that reduce stomach acid) for GERD, so you may need to continue taking them.
What prior data suggests that this mHealth app is safe for GERD patients?
Research has shown that the mHealth Question Prompt List app improves communication between patients with GERD and their doctors. The app helps patients ask better questions about their condition. Although specific safety data for the app is unavailable, it involves no medications or medical procedures, suggesting it is likely very safe to use. The app aims to help manage GERD symptoms by enhancing patient-doctor communication. As a digital tool, most people should find it easy to use.12345
Why are researchers excited about this trial?
Unlike the standard care for acid reflux, which typically involves medications like proton pump inhibitors and lifestyle changes, the mHealth Question Prompt List app offers a unique, app-based approach to managing the condition. This app is designed to enhance communication between patients and healthcare providers by using a gamified question prompt list to improve medication adherence. Researchers are excited about this approach because it leverages mobile technology to potentially increase patient engagement and adherence to treatment plans, which could lead to better management of acid reflux symptoms.
What evidence suggests that this mHealth app is effective for GERD?
Research has shown that the mHealth Question Prompt List app could benefit people with gastroesophageal reflux disease (GERD). In one study, patients accepted 84.6% of the questions in an early version of the GERD question list, indicating the questions were relevant and useful. In this trial, some participants will use the mHealth app, designed to help patients ask better questions during doctor visits, potentially improving symptom management. Early feedback suggests it could simplify and enhance GERD management by improving communication with healthcare providers.12467
Who Is on the Research Team?
Afrin N Kamal, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for individuals with a clinical diagnosis of GERD, experiencing chronic symptoms despite using proton pump inhibitors (PPIs). Participants must have a GerdQ score of 8 or higher, access to the internet and a mobile device or computer, and be able to give consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Focus Group (Aim 1)
Participants give feedback about day-to-day challenges with GERD
Focus Group (Aim 2)
Participants give feedback about mobile health app prototype
mHealth app (Aim 3)
Participants will be exposed to an app-based question prompt list with gamification features to promote medication adherence
Follow-up
Participants are monitored for patient activation and health-related quality of life
What Are the Treatments Tested in This Trial?
Interventions
- mHealth Question Prompt List app
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator